Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial was looking at a drug called motesanib with paclitaxel and carboplatin for non small cell lung cancer (NSCLC). The people taking part had NSCLC that had spread to another part of the body (advanced cancer) and was either an adenocarcinoma or large cell carcinoma type.
Recruitment start: 18 September 2007
Recruitment end: 2 April 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Charles Brigden
Amgen
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 04 Dec 2013
CRUK internal database number: 2449
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
